Back to discover

Protein / target

Interferon regulatory factor 3

Encoded byIRF3Q14653Homo sapiensSwiss-Prot
Degrader-tractable
Druggability
UniProt Ubiquitination
3
Research papers

Protein at a glance

Biological role

Sequence-specific double-stranded DNA binding

Strongest disease association

Skin Neoplasms

Via encoding gene IRF3 · Genetic evidence · score 0.53

Research activity

Emerging research

3 papers · latest 2024

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Key transcriptional regulator of type I interferon (IFN)-dependent immune responses which plays a critical role in the innate immune response against DNA and RNA viruses.

View complete UniProt function annotation

Key transcriptional regulator of type I interferon (IFN)-dependent immune responses which plays a critical role in the innate immune response against DNA and RNA viruses (PubMed:22394562, PubMed:24049179, PubMed:25636800, PubMed:27302953, PubMed:31340999, PubMed:36603579, PubMed:8524823, PubMed:39362857). Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters (PubMed:11846977, PubMed:16846591, PubMed:16979567, PubMed:20049431, PubMed:32972995, PubMed:36603579, PubMed:8524823). Acts as a more potent activator of the IFN-beta (IFNB) gene than the IFN-alpha (IFNA) gene and plays a critical role in both the early and late phases of the IFNA/B gene induction (PubMed:16846591, PubMed:16979567, PubMed:20049431, PubMed:36603579). Found in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, is phosphorylated by IKBKE and TBK1 kinases (PubMed:22394562, PubMed:25636800, PubMed:27302953, PubMed:36603579). This induces a conformational change, leading to its dimerization and nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which activates the transcription of the type I IFN and ISG genes (PubMed:16154084, PubMed:27302953, PubMed:33440148, PubMed:36603579). Can activate distinct gene expression programs in macrophages and can induce significant apoptosis in primary macrophages (PubMed:16846591). In response to Sendai virus infection, is recruited by TOMM70:HSP90AA1 to mitochondrion and forms an apoptosis complex TOMM70:HSP90AA1:IRF3:BAX inducing apoptosis (PubMed:25609812). Key transcription factor regulating the IFN response during SARS-CoV-2 infection (PubMed:33440148)

Subcellular location

CytoplasmNucleusMitochondrion
Domains and Gene Ontology detail (43)

Gene Ontology

  • Cchromatin
  • Ccytoplasm
  • Ccytosol
  • Cmitochondrion
  • Cnucleoplasm
  • Cnucleus
  • FDNA binding
  • FDNA-binding transcription activator activity
  • FDNA-binding transcription activator activity, RNA polymerase II-specific
  • FDNA-binding transcription factor activity
  • FDNA-binding transcription factor activity, RNA polymerase II-specific
  • FDNA-binding transcription repressor activity, RNA polymerase II-specific

427 aa · 47 kDa · 5 isoforms

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Transcriptional regulationUniProt · GOImmune signallingUniProt · GOApoptosis & cell deathGO
View supporting evidence

Transcriptional regulation

  • ·Key transcriptional regulator of type I interferon (IFN)-dependent immune responses whic…
  • ·DNA-binding transcription activator activity
  • ·DNA-binding transcription activator activity, RNA polymerase II-specific
  • ·DNA-binding transcription factor activity

Immune signalling

  • ·Key transcriptional regulator of type I interferon (IFN)-dependent immune responses whic…
  • ·antiviral innate immune response
  • ·positive regulation of cytokine production involved in inflammatory response

Apoptosis & cell death

  • ·apoptotic process
  • ·macrophage apoptotic process
  • ·regulation of apoptotic process

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene IRF3

Gene-level evidence surfaced through the gene IRF3that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Skin Neoplasms
0.54Moderately supported

Genetic evidence dominant · Open Targets 0.32

Schizophrenia
0.51Moderately supported

Genetic evidence dominant · Open Targets 0.30

Basal cell carcinoma
0.47Limited support

Genetic evidence dominant · Open Targets 0.28

Hashimoto's Disease
0.46Limited support

Genetic evidence dominant · Open Targets 0.28

Hypothyroidism
0.41Limited support

Genetic evidence dominant · Open Targets 0.25

View evidence synthesis (5)
Skin NeoplasmsModerately supported
0.54
agreement 0.400.68
Genetic99%Literature1%

Open Targets aggregate 0.32 · 2 independent evidence families

SchizophreniaModerately supported
0.51
agreement 0.370.65
Genetic92%Literature9%

Open Targets aggregate 0.30 · 2 independent evidence families

Basal cell carcinomaLimited support
0.47
agreement 0.330.60
Genetic99%Literature1%

Open Targets aggregate 0.28 · 2 independent evidence families

Hashimoto's DiseaseLimited support
0.46
agreement 0.340.58
Genetic100%

Open Targets aggregate 0.28 · 1 independent evidence family

HypothyroidismLimited support
0.41
agreement 0.270.55
Genetic98%Literature2%

Open Targets aggregate 0.25 · 2 independent evidence families

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Severe Acute Respiratory Syndrome0.48
COVID-190.47
Neurodegenerative Diseases0.36
Skin Neoplasms0.32
Schizophrenia0.30
Basal cell carcinoma0.28
Hashimoto's Disease0.28
Hypothyroidism0.25
Thyroiditis, Autoimmune0.23

Tractability

Protein degradersEmerging

Feasibility evidence (uniprot ubiquitination and database ubiquitination) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (3)
PR · UniProt UbiquitinationPR · Database UbiquitinationPR · Half-life Data

Raw Open Targets tractability assessment buckets, by modality.

Research activity

3 papers · to 2024

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Recent

Europe PMC papers linked directly to this protein.

Related family literature

2

Papers about “Interferon Regulatory Factors” — a broader family this protein belongs to. Shown as context; not counted as papers specifically about this protein.

Interferon-Stimulated Genes: What Do They All Do?

Schoggins JW · Annual review of virology · 2019

via Interferon Regulatory Factors

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.

Zhang F · Nature communications · 2019

via Interferon Regulatory Factors

Europe PMC literature, reached through curated HGNC family membership. Membership is a taxonomic relationship — it does not imply this protein participates in every mechanism these papers discuss.